New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- Comparative genomic analysis of intrahepatic cholangiocarcinoma: biopsy type, an
- 1
- 3 years, 1 month ago
- Actionable Mutations Identified in Majority of Genome-Sequenced Resected Cholang
- 1
- 3 years, 1 month ago
- Practical considerations in screening for genetic alterations in cholangiocarcin
- 1
- 3 years, 1 month ago
- Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin (AL
- 1
- 3 years, 1 month ago
- Investigation of a Tumor Location-Specific Therapeutic Strategy for Intrahepatic
- 1
- 3 years, 1 month ago
- Genomic profiling of biliary tract cancers to reveal clinically actionable genes
- 1
- 3 years, 1 month ago
- Efficacy of immunotherapy in hepatocholangiocarcinoma (HCC-CC): Proof of concept
- 1
- 3 years, 1 month ago
- Molecular alterations, tumor microenvironment and clinical correlations in Thai
- 1
- 3 years, 1 month ago
- Detection of FGFR fusions in intrahepatic cholangiocarcinoma using targeted RNA
- 1
- 3 years, 1 month ago
- Comprehensive molecular characterization of Chinese patients with intrahepatic a
- 1
- 3 years, 1 month ago
- Next Tumor-informed assessment of circulating tumor DNA and its incorporation in
- 1
- 3 years, 1 month ago
- Clinical activity and safety of the RET inhibitor pralsetinib in patients with R
- 1
- 3 years, 1 month ago
- The forum ‘New Developments’ is closed to new topics and replies.